USANA Health Sciences (USNA) Misses Q4 EPS by 25c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
USANA Health Sciences Reports Fiscal Year and Fourth Quarter 2021 Results
February 8, 2022 4:15 PM ESTSALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its full year and fiscal fourth quarter ended January 1, 2022.
Key Financial & Operating Highlights
Fiscal year 2021 net sales grew 5% to $1.186 billion. Reported fiscal year 2021 diluted EPS totaled $5.73. Fourth quarter net sales reached $267 million and diluted EPS were $1.03. Company provides initial 2022 net sales guidance of $1.125 to $1.225 billion and initial diluted EPS guidance of $5.25 to $6.00.The Company maintains a 52/53-week fiscal year. Fiscal 2020 was a 53-week year and included one additional week... More
